For more VICC news, visit their website »
Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch.
Physical fatigue, anxiety and emotional distress are just some of the symptoms that caregivers may experience while undertaking the hard work of helping a friend or loved one cope with cancer.
Join an upcoming live Facebook Chat in which Vanderbilt-Ingram Cancer Center experts will answer your questions about hereditary cancer risk on Sept. 24 at 6 p.m.
Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.
A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.
The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.